-
Ukraine claims US missile holdup ahead of reported talks
-
US bans use of China's DeepSeek by govt agencies
-
Niners hold off Commanders to stay perfect in NFL
-
Middle East fuel crunch drives solar push in tiny Fiji
-
Tech firms bear brunt of selling as Asian stocks drop
-
Indian rappers use music to sound climate alarm
-
Reese scores 30 as Dream stun Valkyries to level WNBA finals
-
Japan probe on its way to Mars moon
-
Horror and disbelief after lawmaker attacked in rural Australia
-
Lula or Bolsonaro's son? Brazil makes a final choice
-
Ukraine races to secure energy supplies ahead of winter
-
EU unveils strategy to boost Arctic presence
-
Vote count begins in Alberta secession referedum, testing Canada unity
-
How to Raise Financially Savvy Teenagers
-
How to Use an Allowance to Teach Money Skills
-
How recent controversies have rocked the US death penalty debate
-
Ukraine claims US missile holdup as Trump floats summit without Zelensky
-
Adams facing long injury layoff as Rams' problems deepen
-
Detained Suu Kyi receives UK royal package: Myanmar govt
-
US judge orders Saudi engineer held in OpenAI case
-
Japan successfully launches probe in historic Mars moon mission
-
Maddison sparkles as Spurs end Premier League winless run
-
US to auction deep sea mining leases off American Samoa
-
Maddison sparkles on Spurs return as win drought ends
-
Australian lawmaker hurt in car attack underwent surgery overnight: PM
-
Trump says ready to meet with Putin and Xi in China
-
Japan launches rocket for potential world first Mars moon mission
-
The young lawmaker making Brazil's Lula 'king of the selfie'
-
Ethiopia PM warns Eritrea of 'severe consequences' if supports enemies
-
Christiane Amanpour to leave CNN after 43 years
-
Boland grabs opportunity for Australia as South Africa struggle in second Test
-
Ronaldo handed 30-day suspension after walking out on Portugal
-
Ronaldo handed 30-day suspension: Portuguese federation
-
Netanyahu basks in Trump endorsement week before election
-
France announces curfews as government grapples with unrest
-
Saudi airport closure disrupts life in kingdom's capital
-
Boland sets pace as South Africa struggle
-
Ramaphosa tells South Africa to prepare for loss of US-Africa trade deal
-
Ukraine on back foot as Kremlin moots US, China meeting
-
France presses resale platforms to remove 'stolen' goods after unrest
-
'Stay home!': Tourists find themselves in a France convulsed by protests
-
Yamal v PSG: Ballon d'Or backdrop to Champions League showdown
-
Kenyan cult leader guilty on all charges over 191 starvation deaths
-
Araujo says too soon to talk about permanent Liverpool move
-
Eagles star Hurts to miss rest of NFL season: reports
-
US wants to be 'strong partner' for central Asia: Rubio
-
Oil-rich Alberta votes on Canada breakup
-
'Special' to face friend Perez in Champions League, says Liverpool's Iraola
-
Israel announces arrests after West Bank settler attacks on Westerners
-
Monitor says Indonesia fires have burned nearly two million hectares
Charlie's Holdings (OTCQB:CHUC) Selected for FDA Premarket Tobacco Product Applications Meeting
Charlie's Director, Dr. Ed Carmines, an expert on regulatory submissions and product safety, will discuss Pharmacological Profiles at the prestigious FDA roundtable.
COSTA MESA, CA / ACCESS Newswire / February 10, 2026 / Charlie's Holdings, Inc.(OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Center for Tobacco Products of the U.S. Food and Drug Administration ("FDA") selected Charlie's Board member, Ed Carmines, PhD, to serve as a panelist for the Roundtable on Premarket Tobacco Product Application ("PMTA") Submissions for Electronic Nicotine Delivery Systems ("ENDS") that will be held at 9:00am (Eastern Time) today at FDA Headquarters in Silver Spring, Maryland.
Dr. Ed Carmines, Chief Scientific Officer of Chemular, Inc, and independent Board Member of Charlie's Holdings, is a world-renowned expert in the technical aspects of all types of e-cigarettes, oral tobacco, tobacco-free products, cigars, and cigarettes. Having successfully navigated the FDA's Substantial Equivalence, PMTA, and Modified Risk Tobacco Product Application ("MRTPA") pathways for literally thousands of products, Dr. Carmines spearheaded development and licensing of proprietary technology to enable Charlie's to offer a controlled e-cigarette device that is made operable only upon activation by an age-verified adult consumer.
By launching this strategic initiative, Charlie's has endeavored to make the Company's PACHA™ disposable e-cigarette products the first flavored e-cigarettes able to be sold legally in the United States.
During today's FDA roundtable, Dr. Carmines will discuss pharmacokinetic studies around Charlie's PACHA products as well as studies of adult benefits related to flavored ENDS products that could result in Charlie's becoming the first Company to demonstrate to the FDA that age-gated flavored vape products are indeed 'appropriate for the protection of public health.'
The FDA roundtable discussion will be available for viewing online.
For more information about providing comments, orally or in writing, please see the Federal Register notice.
About Charlie's Holdings, Inc.
Charlie's Holdings, Inc. (OTCQB:CHUC) is an industry leader in the premium vapor products space. The Company's products are sold around the world to select distributors, specialty retailers, and third-party online resellers through subsidiary company Charlie's Chalk Dust, LLC has developed an extensive portfolio of brand styles, flavor profiles, and innovative product formats.
For additional information, please visit Charlie's corporate website at: Chuc.comand the Company's branded online websites: sbxvape.com, CharliesChalkDust.com, enjoypachamama.com, and Pacha.co.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company's overall business, existing and anticipated markets and expectations regarding future sales and expenses. Words such as "expect," "anticipate," "should," "believe," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "could," "intend," variations of these terms or the negative of these terms, and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. The Company's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company's ongoing ability to quote its shares on the OTCQB; whether the Company will meet the requirements to up-list to a national securities exchange in the future; the Company's ability to successfully increase sales and enter new markets; whether the Company's PMTA's for its nicotine-containing products will be authorized by the FDA, and the FDA's decisions with respect to the Company's future PMTA's for nicotine products; the Company's ability to manufacture and produce products for its customers; the Company's ability to formulate new products; the acceptance of existing and future products; the complexity, expense and time associated with compliance with government rules and regulations affecting nicotine, synthetic nicotine, products containing nicotine substitutes, and products containing cannabidiol; litigation risks from the use of the Company's products; risks of government regulations; the impact of competitive products; and the Company's ability to maintain and enhance its brands, as well as other risk factors included in the Company's most recent quarterly report on Form 10-Q, annual report on Form 10-K, and other SEC filings. These forward-looking statements are made as of the date of this press release and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.
Investors Contact:
[email protected]
Phone: 949-570-0691
SOURCE: Charlie's Holdings, Inc.
View the original press release on ACCESS Newswire
M.O.Allen--AT